Silence Therapeutics PLC at Cowen Healthcare Conference (Virtual) Transcript
Awesome. Good morning, everyone. Welcome to Cowen's 41st Annual Healthcare Conference. I'm Anvita Gupta from the biotech research team here, and I'm delighted to introduce Silence Therapeutics for this corporate presentation.
With us today, we have Mark Rothera, President and CEO of Silence. (Operator Instructions)
And so with that, the floor is all yours, Mark.
Thank you, Anvita. And thank you, Cowen, for the invitation. I'm delighted to be here today.
Silence is in a tremendous place. It's a precision medicines company, working in the RNAi arena. And for various reasons that I'll go through, I think it's really poised to take off.
If we go to the next slide, please. During the course of this presentation, I'll make some forward-looking statements. Thank you.
Next slide. So as I was mentioning, I think this year is a really important year in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |